Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Infect Dis. 2014 Jul 15;210(2):254-64. doi: 10.1093/infdis/jiu049. Epub 2014 Jan 19.

Transferrin iron starvation therapy for lethal bacterial and fungal infections.

Author information

  • 1The Los Angeles Biomedical Research Institute, Torrance, California The Division of General Internal Medicine, Harbor-University of California at Los Angeles (UCLA) Medical Center, Torrance The David Geffen School of Medicine at UCLA, Los Angeles.
  • 2The Los Angeles Biomedical Research Institute, Torrance, California.
  • 3Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee.

Abstract

New strategies to treat antibiotic-resistant infections are urgently needed. We serendipitously discovered that stem cell conditioned media possessed broad antimicrobial properties. Biochemical, functional, and genetic assays confirmed that the antimicrobial effect was mediated by supra-physiological concentrations of transferrin. Human transferrin inhibited growth of gram-positive (Staphylococcus aureus), gram-negative (Acinetobacter baumannii), and fungal (Candida albicans) pathogens by sequestering iron and disrupting membrane potential. Serial passage in subtherapeutic transferrin concentrations resulted in no emergence of resistance. Infected mice treated with intravenous human transferrin had improved survival and reduced microbial burden. Finally, adjunctive transferrin reduced the emergence of rifampin-resistant mutants of S. aureus in infected mice treated with rifampin. Transferrin is a promising, novel antimicrobial agent that merits clinical investigation. These results provide proof of principle that bacterial infections can be treated in vivo by attacking host targets (ie, trace metal availability) rather than microbial targets.

© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

KEYWORDS:

Acinetobacter baumannii; Candida albicans; Staphylococcus aureus; in vivo treatment; iron; transferrin

PMID:
24446527
[PubMed - indexed for MEDLINE]
PMCID:
PMC4092247
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk